DAVID GRANOVSKY

Stem Cell Research News Stories

In STEM CELLS IN THE NEWS on September 8, 2009 at 1:04 pm

A collection of the latest Stem Cell Research News stories

from “Medical News Today”

GeneX(R) Used In Pioneering Stem Cell Research

Professor James B. Richardson of the Robert Jones and Agnes Hunt Orthopaedic Hospital, Oswestry, UK has been carrying out pioneering work combining geneX with selected and culture expanded Mesenchymal stem cells to treat fracture non-unions. The stem cells are collected in a sample of bone marrow, then purified and cultured expanded at the Oscell GMP laboratory (http://www.oscell.enta.

8:12 AM (4 hours ago)

Induced Pluripotent Stem Cells Easily Converted From Liposuction Leftovers: Stanford Study

Globs of human fat removed during liposuction conceal versatile cells that are more quickly and easily coaxed to become induced pluripotent stem cells, or iPS cells, than are the skin cells most often used by researchers, according to a new study from Stanford’s School of Medicine. “We’ve identified a great natural resource,” said Stanford surgery professor and co-author of the research, Michael Longaker, MD, who has called the readily available liposuction leftovers “liquid gold.

Sep 5, 2009 (3 days ago)

Survival Prolonged In Mouse Model Of Rare Brain Disease By Transplanted Human Stem Cells

A new study finds substantial improvement in a mouse model of a rare, hereditary neurodegenerative disease after transplantation of normal human neural stem cells.

Sep 4, 2009 (4 days ago)

Tighter Controls Needed On ‘Stem Cell Tourism’ Say European And Chinese Experts

Vulnerable patients who travel abroad for unproven and potentially unsafe stem cell treatments need to be better protected says a report published by a team of expert researchers from Europe and China today. The report calls for countries to develop more effective regulation of experimental stem cell procedures by insisting on rigorous clinical studies and ethical reviews before they can be offered as treatments.

Sep 3, 2009 (5 days ago)

Brain Tissue In Traumatic Injuries Regenerated By Clemson University Researcher

An injectable biomaterial gel may help brain tissue grow at the site of a traumatic brain injury, according to findings by a Clemson University bioengineer. Research by assistant professor of bioengineering Ning Zhang shows that the biomaterial gel made up of both synthetic and natural sources has the potential to spur the growth of a patient’s own neural stem cells in the body, structurally repairing the brain injury site.

Sep 3, 2009 (5 days ago)

Study Results Promise Faster Recovery From Life-Threatening Blood Cell Shortages

A key compound resupplies bone marrow with fast-acting stem cells that can more quickly rekindle blood cell production, according to a study published online today in the journal Blood. While the study was in mice, in the study authors say it has the potential to increase survival among patients with life-threatening blood cell shortages. Thanks to stem cells, humans develop from one cell into a complex being with as many as 400 cell types.

Sep 2, 2009 (6 days ago)

TCA Cellular Therapy Presents Adult Stem Cell Findings To European Society Of Cardiology Congress

This week TCA Cellular Therapy`s Medical Director Gabriel Lasala, M.D. presents advances in adult stem cell treatments for severe limb ischemia and refractory coronary ischemia at the European Society of Cardiology Congress in Barcelona, Spain.

Sep 2, 2009 (6 days ago)

New Method For Safer Bone Marrow Transplants For Sick Children

An article published Online First and in a future edition of The Lancet reports that minimal-intensity conditioning (MIC) regimen using antibodies instead of high dose chemotherapy may reduce the short and long term toxicity related with stem cell transplants in children. This could allow successful transplantation even in the sickest children.

Sep 1, 2009 10:17 AM

Rhode Island Hospital Awarded $11 Million, 5-Year Renewal

Rhode Island Hospital has received an $11 million renewal of a National Institutes of Health (NIH) grant to fund its Center of Biomedical Research Excellence (COBRE) Center for Cancer Research Development (CCRD). Rhode Island Hospital’s COBRE CCRD offers cancer researchers access to the latest technologies in molecular pathology and the emerging field of proteomics.

Aug 31, 2009 6:55 AM

Roche XCELLigence System For Cell Analysis To Provide Predictive Mechanistic Information For Small Molecule Compounds

The extent to which protein targets are modulated by drugs or small molecule compounds depends on a number of factors, including the expression levels of the target, the effective concentration of the compound, and the time needed for the compound to perturb the target. One of the limitations of current multidimensional phenotypic profiling approaches is that typically a single time point is chosen to assess the effect of compounds.

Aug 28, 2009 8:07 AM

USC Researchers Receive $2.9 Million In Stem Cell Research Funding

Researchers at the Keck School of Medicine of the University of Southern California (USC) have been awarded $2.9 million in grants from the California Institute for Regenerative Medicine (CIRM) to support research into stem cell discoveries that lay the foundation for future therapies. The Basic Biology Awards received formal approval Thursday from the Independent Citizens Oversight Committee (ICOC), the 29-member governing board of the institute.

Aug 27, 2009 10:03 AM

Research Into The Role Of Pathway Gene Could Provide Novel Method To Treat Cancer Metastases

Scientists in Switzerland have discovered a way to block the growth of human colon cancer cells, preventing the disease from reaching advanced stages and the development of liver metastases. The research, published today in EMBO Molecular Medicine, shows that blocking the so-called Hedgehog-GLI pathway can prevent the growth of tumours, metastatic lesions and cancer stem cells, the cells thought to lie at the root of cancer growth.

Aug 25, 2009 11:24 AM

Protein Delivery Improves Liver Stem Cell Engraftment

Researchers at INSERM (France) have engineered a chimeric protein that increases cell survival, migration and proliferation to improve stem cell engraftment. The results, which appear in the September 2009 issue of Experimental Biology and Medicine, show that TAT-Tpr-Met, a cell permeable form of the hepatocyte growth factor receptor can increase the number of hepatic stem cells integrated into the liver of the mouse.

Aug 25, 2009 7:24 AM

Study Finds Promise In Combined Transplant/Vaccine Therapy For High-risk Leukemia

Two of the most powerful approaches to cancer treatment — a stem cell transplant and an immune system-stimulating vaccine — appear to reinforce each other in patients with an aggressive, hard-to-control form of leukemia, Dana-Farber Cancer Institute scientists have found. In a study to be published in the online early edition of the Proceedings of the National Academy of Sciences the week of Aug.

Aug 25, 2009 7:24 AM

Team Grows Retina Cells From Skin-derived Stem Cells

A team of scientists from the University of Wisconsin-Madison School of Medicine and Public Health has successfully grown multiple types of retina cells from two types of stem cells suggesting a future in which damaged retinas could be repaired by cells grown from the patient’s own skin.

Aug 25, 2009 6:10 AM

‘Glow In The Dark’ Red Blood Cells Made From Human Stem Cells, Australia

Victorian stem cell scientists from Monash University have modified a human embryonic stem cell (hESC) line to glow red when the stem cells become red blood cells. The modified hESC line, ErythRED, represents a major step forward to the eventual aim of generating mature, fully functional red blood cells from human embryonic stem cells.

Aug 22, 2009 7:29 AM

Insight Into How Stems Cells Develop Into Other Types Of Cells

Scientists have uncovered a vital link in the chain of events that gives stem cells their remarkable properties. Researchers from the Wellcome Trust Centre for Stem Cell Research at the University of Cambridge have pinpointed the final step in a complex process that gives embryonic stem cells their unique ability to develop into any of the different types of cells in the body (from liver cells to skin cells).

Aug 22, 2009 7:29 AM

Stemedica Requests Pre-IND Meeting With FDA

Stemedica Cell Technologies, Inc. USA, a leader in adult stem cell research and manufacturing, has requested a pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration (“FDA”) to discuss a proposed IND to use Stemedica’s proprietary line of allogeneic mesenchymal bone marrow cells (adult human) as a treatment for ischemic stroke.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: